Integrated Proteins Limited has scheduled an Extraordinary General Meeting (EGM) for August 20, 2026, to approve a 1:10 sub-division of its equity shares, aiming to enhance market liquidity and broaden investor accessibility. The company will also seek shareholder consent to regularize the appointments of two directors, including the re-appointment of its Chairman and Managing Director, Hiren Dhirajlal Shah, for a five-year term. This structural adjustment allows retail investors easier entry by lowering the absolute price point per share, although total market capitalization remains unchanged.

The EGM will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM), in compliance with Ministry of Corporate Affairs (MCA) General Circulars No. 03/2025 and subsequent directives permitting virtual meetings. The meeting is scheduled to begin at 1:00 P.M. on August 20, 2026. Shareholders holding shares as on the record date of August 13, 2026, are eligible to vote. Remote e-voting facilities will be available from August 17, 2026, at 9:00 A.M. to August 19, 2026, at 5:00 P.M., facilitated by National Securities Depository Limited (NSDL).

Share Sub-Division and Capital Alteration

The primary agenda item involves the sub-division of existing equity shares with a face value of ₹10 into ten equity shares with a face value of ₹1 each. This stock split will not alter the aggregate amount of the company’s authorized, issued, subscribed, and paid-up share capital, which remains at ₹25,00,00,000 (₹25 crore). Consequently, the authorized share capital structure will change from 2,50,00,000 shares of ₹10 each to 25,00,00,000 shares of ₹1 each.

The Board of Directors approved this proposal on July 9, 2026, subject to shareholder approval and necessary regulatory consents from BSE Limited. The company will apply for new International Securities Identification Numbers (ISINs) for the subdivided shares from NSDL and Central Depository Services (India) Limited (CDSL). Physical share certificates will be deemed cancelled, and new certificates or confirmation letters will be issued by the Registrar and Share Transfer Agent (RTA), Cameo Corporate Services Limited, without requiring members to surrender existing certificates.

Director Regularizations

Shareholders will also vote on two director-related resolutions:

• Nitish Pratapray Mehta: Regularization as a Non-Executive Non-Independent Director. Mr. Mehta was appointed as an Additional Director on July 9, 2026, and holds office until the date of this EGM. His regularization is required under Section 161 of the Companies Act, 2013.
• Hiren Dhirajlal Shah: Re-appointment as Chairman and Managing Director for a term of five years, from July 24, 2026, to July 23, 2031. This appointment requires a Special Resolution under Regulation 17(1C) of the SEBI Listing Regulations. His remuneration includes a basic salary of ₹96,000 per annum, along with perquisites such as housing allowance and special allowances.

What the Numbers Show

The proposed 1:10 share split is a structural adjustment rather than a financial expansion. By reducing the face value from ₹10 to ₹1, Integrated Proteins aims to lower the absolute price point of its shares, potentially attracting retail investors who may find the previous pricing tier less accessible. The total market capitalization remains unchanged by the split itself; however, increased share count may influence trading volume and liquidity metrics in the secondary market. The simultaneous regularization of leadership roles suggests a focus on governance stability alongside these capital structure changes.

Integrated Proteins has accepted the resignation of Shivangi Paliwal from her roles as Company Secretary and Compliance Officer, effective July 27, 2026. The Board of Directors approved the departure during a meeting held at the company’s registered office in Jamnagar, Gujarat, on July 27, 2026. Paliwal cited personal reasons for her exit, with no other material causes disclosed in the filing. This change creates an immediate vacancy in a key governance role responsible for regulatory compliance.

The resignation was processed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Integrated Proteins submitted the disclosure to BSE Limited on July 27, 2026, referencing SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. Paliwal was relieved from all official responsibilities and statutory positions at the closing business hours of July 27, 2026.

Resignation Details

Paliwal, who holds membership number A80556, tendered her resignation via a letter dated July 27, 2026. The letter confirmed her exit from the role of Key Managerial Personnel and all other statutory or designated positions within the company. She expressed gratitude to the Board of Directors and colleagues for their support during her tenure.

Board Meeting Proceedings

The Board Meeting commenced at 17:00 HRS (IST) and concluded at 17:30 HRS (IST) on July 27, 2026. Hiren Dhirajlal Shah, Director (DIN: 09842161), signed the disclosure on behalf of Integrated Proteins Limited. The company is required to submit the necessary forms to the Registrar of Companies to formalize the change in key managerial personnel.

Governance Impact

The departure of the Company Secretary and Compliance Officer creates an immediate vacancy in a critical governance role responsible for regulatory compliance and corporate secretarial matters. Investors should monitor subsequent filings for the appointment of a successor to ensure continuity in compliance oversight.